TELA Bio, Inc. Foreign Income Tax Expense (Benefit), Continuing Operations
TELA Bio, Inc. (TELA) reported Foreign Income Tax Expense (Benefit), Continuing Operations of -$100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2025-03-21
- TELA Bio, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2024 was -$100.00K.
- TELA Bio, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2023 was $0.00.
- TELA Bio, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2022 was $0.00.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2024-12-31 | -$100.00K 10-K · filed 2025-03-21 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-21 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |